REMS- und RMP-Unterstützung

Ein REMS (Risk Evaluation and Mitigation Strategy) oder RMP (Risk Management Plan) ist ein von den Zulassungsbehörden vorgeschriebenes Risikomanagementprogramm, das darauf abzielt, arzneimittelbezogene Risiken gezielt zu erkennen, zu minimieren und zu überwachen.

Customer service professional in a contact center wearing headset asking a coworker-a-question

Diese Programme stellen sicher, dass Patient*innen Zugang zu notwendigen Arzneimitteln erhalten – bei gleichzeitiger Minimierung potenzieller Risiken. REMS (Risk Evaluation and Mitigation Strategies) bzw. RMP (Risk Management Plans) zielen darauf ab, ein spezifisches schwerwiegendes Risiko zu verhindern, zu überwachen und zu steuern. Dies geschieht durch gezielte Information, Schulung und die Förderung sicherheitsrelevanter Maßnahmen, um die Wahrscheinlichkeit und Schwere unerwünschter Ereignisse zu verringern. Solche Programme stärken das Bewusstsein für einen sicheren Umgang mit Arzneimitteln und vermitteln allen beteiligten Akteur*innen – insbesondere medizinischem Fachpersonal – wichtige Vorsichtsmaßnahmen. Die Contact Center-Services von ProPharma unterstützen REMS- und RMP-Programme, indem sie als zentrale Anlaufstelle für Patient*innen und medizinisches Fachpersonal fungieren. Unsere Dienstleistungen sind weltweit verfügbar – in über 40 Sprachen und angepasst an lokale Arbeitszeiten und Feiertage. Wir bieten skalierbare, flexible und individuell anpassbare Lösungen, um ein wachsendes REMS-Portfolio effizient zu begleiten. In enger Zusammenarbeit mit unseren Kund*innen teilen wir bewährte Verfahren, die Innovation und Effizienz gleichermaßen fördern. Unser Engagement für kontinuierliche Serviceverbesserung zeigt sich im Einsatz moderner Technologien – darunter Tools für Workforce-Management, digitale Kommunikationskanäle (z. B. Chatbots und Live-Chats) und Zufriedenheitsbefragungen. Darüber hinaus testen wir Telefonleitungen sowie z.B. Webformulare oder Emailkonten manuell oder automatisiert, je nach Anforderung.

Medical Information icon

Kommunkation

Kommunkation

Document search icon

Produktzugang und -information

Produktzugang und -information

Decentralized Clinical Trials icon

Management von unerwünschten Ereignissen (UE)

Management von unerwünschten Ereignissen (UE)

Medical writing icon

Training und Edukation

Training und Edukation

Anfragen-Support

  • Weltweite Verfügbarkeit: ProPharma ist global tätig und bietet Unterstützung in allen unterstützten Sprachen – abgestimmt auf lokale Zeitzonen und regionale Gegebenheiten.
  • Multichannel-Kommunikation: Die Betreuung erfolgt über verschiedene Kanäle wie Telefon, Chat, E-Mail und weitere Kommunikationsplattformen.
  • Fachkundige Bearbeitung: Wir fördern eine informierte Entscheidungsfindung im Gesundheitswesen durch verlässliche Informationen und strukturierte Kommunikation.
  • Unterstützung fundierter Entscheidungen: Wir fördern eine informierte Entscheidungsfindung im Gesundheitswesen durch verlässliche Informationen und strukturierte Kommunikation.Facilitates informed decision-making for healthcare providers.
  • Zugängliche Wissensressourcen: ProPharma unterhält eine zentrale Sammlung von Antwortdokumenten sowie eine umfassende Datenbank aller eingereichten Anfragen.
  • Regelmäßige Berichterstattung: ProPharma stellt eine konsistente und detaillierte Berichterstattung sicher.
  • Compliance und kulturelle Sensibilität: Unsere Services entsprechen den jeweils geltenden gesetzlichen Vorgaben und berücksichtigen lokale und kulturelle Besonderheiten.
Confident worker woman looking at camera

Produktzugang und -information

  • Wichtige Informationen zum Produktzugang: Bereitstellung essenzieller Informationen, um den Zugang zu kritischen Produkten sicherzustellen.
  • Effiziente Verteilung: Optimierung der Verteilung von RMP-Materialien – sowohl elektronisch als auch in gedruckter Form.
  • Apotheken- und Programmsuche: Unterstützung bei der Suche nach Apotheken und Programmen, die den Zugang zu REMS-pflichtigen Arzneimitteln ermöglichen.
  • Patientenunterstützung: Unterstützung für Patient*innen, die mit finanziellen oder zugangsbezogenen Hürden konfrontiert sind.
Several business professionals having fun at a business meeting

Management von unerwünschten Ereignissen (UE)

  • Erkennung und Aufnahme von unerwünschten Ereignissen: Unser erfahrenes Team identifiziert und erfasst unerwünschte Ereignisse effizient. Spezifische REMS-Fragebögen können bei der Aufnahme ausgefüllt werden.
  • Schnelle Reaktion: Sicherheitsbedenken werden zügig erkannt und umgehend an die Kund*innen weitergeleitet.
  • Präzise Triage: Gewährleistung einer genauen Triage und effektiven Kommunikation mit den zuständigen Teams.
  • Beschleunigte Berichterstattung: Einhaltung beschleunigter Meldefristen für unerwünschte Ereignisse.
  • Nachverfolgung nach dem UE: Gründliche Nachverfolgung nach unerwünschten Ereignissen – schriftlich oder telefonisch in der jeweiligen Landessprache.
Business professionals smiling at a desk reviewing data

Training und Edukation

  • Bereitstellung von Schulungsmaterialien: Verteilung von Informationsmaterialien an Patient*innen, darunter Broschüren, Leitfäden und Warnkarten.
  • Aktuelle Informationen: Laufende Information für medizinisches Fachpersonal und Patient*nnen über aktuelle Strategien und Richtlinien im Risikomanagement.
  • Compliance-Reminder: Bereitstellung von Hinweisen und Informationen zu bewährten Verfahren, um die Einhaltung von Vorschriften sicherzustellen.
  • Zertifizierungsüberprüfung: Bewertung und Verifizierung der REMS- bzw. RMP-Zertifizierung von medizinischem Fachpersonal.
  • Unterstützung bei Schulungssitzungen: Begleitung bei Anmeldung und Nachverfolgung von Schulungsveranstaltungen.
Row of professionals working at a conference table

Our REMS and RMP Experts

  • Valerie Huh Bio Photo

    Valerie Huh

    Director, Global Innovation and Implementation

    View Bio

  • Ana Ming Bio Photo

    Ana Ming

    Senior Global Innovation and Implementation Manager

    View Bio

Valerie Huh brings over 20 years of experience in the pharmaceutical and healthcare industries, with expertise in global operations and process improvements. She holds a Doctor of Pharmacy (Pharm.D.), a degree in Chemistry, and an MBA with a certificate in business analytics. In her current role, she leads innovation and technology enablement in Medical Information and supports business expansions, driving forward strategic initiatives to enhance service quality and operational efficiency.

Ana Ming is a highly skilled pharmacist based in Australia, with 12+ years of experience in the pharmaceutical services and healthcare industries. Currently at ProPharma, she brings expertise in medical information management, patient care, and regulatory compliance. Additionally, Ana is a certified Justice of the Peace (JP), combining her healthcare experience with a commitment to community service and ethical leadership. Her collaborative approach, coupled with a focus on innovative solutions, makes her a valuable asset in optimizing patient outcomes and advancing pharmaceutical practices.

REMS- und RMP-Contact Center-Support

Sorgen Sie für einen sicheren Umgang mit Arzneimitteln und minimieren Sie Risiken mit den REMS-/RMP-Support-Services von ProPharma. Unsere weltweit zugänglichen Lösungen bieten fachkundige Unterstützung für Patient*innen und medizinisches Fachpersonal – in über 40 Sprachen. So stärken wir das Risikomanagement durch fundierte Entscheidungen und verlässliche Kommunikationskanäle.

News & Insights

Responsible AI in Medical Information: Safety, Ownership, Oversight

Juni 29, 2026

Responsible AI in Medical Information: Safety, Ownership, Oversight

Explore the critical role of responsible AI in medical information, focusing on safety, data ownership, and oversight to enhance patient care and trust.ca

FAQ: In Vitro Diagnostics (IVDs)

Juni 25, 2026

FAQ: In Vitro Diagnostics (IVDs)

Explore emerging trends in in vitro diagnostics (IVDs), from point-of-care testing and miniaturized diagnostics to wearable technologies and evolving regulatory considerations.

A Risk-Based Road Map for Implementing AI

Juni 22, 2026

A Risk-Based Road Map for Implementing AI

Discover a risk-based approach to implementing AI in life sciences, ensuring compliance, transparency, and governance throughout the entire lifecycle.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

Juni 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

Mai 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

Januar 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

Januar 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

Oktober 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

Juni 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

Juni 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

Mai 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Juni 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

Juni 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

News & Insights

Responsible AI in Medical Information: Safety, Ownership, Oversight

June 29, 2026

Responsible AI in Medical Information: Safety, Ownership, Oversight

Explore the critical role of responsible AI in medical information, focusing on safety, data ownership, and oversight to enhance patient care and trust.ca

FAQ: In Vitro Diagnostics (IVDs)

June 25, 2026

FAQ: In Vitro Diagnostics (IVDs)

Explore emerging trends in in vitro diagnostics (IVDs), from point-of-care testing and miniaturized diagnostics to wearable technologies and evolving regulatory considerations.

A Risk-Based Road Map for Implementing AI

June 22, 2026

A Risk-Based Road Map for Implementing AI

Discover a risk-based approach to implementing AI in life sciences, ensuring compliance, transparency, and governance throughout the entire lifecycle.

Previous Post Arrow Next Post Arrow
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

May 27, 2026

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research - ProPharma

Juni 17, 2026

Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sen...

Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate...

Case Study Accelerating Commercial Readiness for a Novel Cell Therapy Program - ProPharma

Juni 10, 2026

Accelerating Commercial Readiness for a Novel Cell Therapy Program

As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and...

Case Study Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

Mai 20, 2026

Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed

When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size...

Previous Resource Arrow Next Resource Arrow
Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Juni 4, 2026

Tech Meets Touch: Evaluating Empathy and AI in Medical Information Delivery

Artificial intelligence (AI) is a hot topic in Medical Information (MI), yet real-world evidence of its impact in regulated, human-led MI environments remains limited. Hear practical, evidence-based...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

Juni 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Previous Webinar Arrow Next Webinar Arrow